These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22931452)

  • 1. Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases.
    Ramalingam S; London V; Kandavelou K; Cebotaru L; Guggino W; Civin C; Chandrasegaran S
    Stem Cells Dev; 2013 Feb; 22(4):595-610. PubMed ID: 22931452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
    Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
    Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
    Yao Y; Nashun B; Zhou T; Qin L; Qin L; Zhao S; Xu J; Esteban MA; Chen X
    Hum Gene Ther; 2012 Feb; 23(2):238-42. PubMed ID: 21981760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.
    Hockemeyer D; Soldner F; Beard C; Gao Q; Mitalipova M; DeKelver RC; Katibah GE; Amora R; Boydston EA; Zeitler B; Meng X; Miller JC; Zhang L; Rebar EJ; Gregory PD; Urnov FD; Jaenisch R
    Nat Biotechnol; 2009 Sep; 27(9):851-7. PubMed ID: 19680244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases.
    Moehle EA; Rock JM; Lee YL; Jouvenot Y; DeKelver RC; Gregory PD; Urnov FD; Holmes MC
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3055-60. PubMed ID: 17360608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells.
    Yan Q; Quan Y; Sun H; Peng X; Zou Z; Alcorn JL; Wetsel RA; Wang D
    Stem Cells; 2014 Feb; 32(2):402-13. PubMed ID: 24123810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme.
    Wang J; Friedman G; Doyon Y; Wang NS; Li CJ; Miller JC; Hua KL; Yan JJ; Babiarz JE; Gregory PD; Holmes MC
    Genome Res; 2012 Jul; 22(7):1316-26. PubMed ID: 22434427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.
    Sebastiano V; Maeder ML; Angstman JF; Haddad B; Khayter C; Yeo DT; Goodwin MJ; Hawkins JS; Ramirez CL; Batista LF; Artandi SE; Wernig M; Joung JK
    Stem Cells; 2011 Nov; 29(11):1717-26. PubMed ID: 21898685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.
    van Rensburg R; Beyer I; Yao XY; Wang H; Denisenko O; Li ZY; Russell DW; Miller DG; Gregory P; Holmes M; Bomsztyk K; Lieber A
    Gene Ther; 2013 Feb; 20(2):201-14. PubMed ID: 22436965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.
    Wang Y; Zhang WY; Hu S; Lan F; Lee AS; Huber B; Lisowski L; Liang P; Huang M; de Almeida PE; Won JH; Sun N; Robbins RC; Kay MA; Urnov FD; Wu JC
    Circ Res; 2012 Dec; 111(12):1494-503. PubMed ID: 22967807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases.
    Cai Y; Bak RO; Mikkelsen JG
    Elife; 2014 Apr; 3():e01911. PubMed ID: 24843011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.
    Zou J; Maeder ML; Mali P; Pruett-Miller SM; Thibodeau-Beganny S; Chou BK; Chen G; Ye Z; Park IH; Daley GQ; Porteus MH; Joung JK; Cheng L
    Cell Stem Cell; 2009 Jul; 5(1):97-110. PubMed ID: 19540188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating designed zinc-finger nucleases with minimal cytotoxicity.
    Ramalingam S; Kandavelou K; Rajenderan R; Chandrasegaran S
    J Mol Biol; 2011 Jan; 405(3):630-41. PubMed ID: 21094162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases.
    Spitalieri P; Talarico RV; Botta A; Murdocca M; D'Apice MR; Orlandi A; Giardina E; Santoro M; Brancati F; Novelli G; Sangiuolo F
    Cell Reprogram; 2015 Aug; 17(4):275-87. PubMed ID: 26474030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
    Crane AM; Kramer P; Bui JH; Chung WJ; Li XS; Gonzalez-Garay ML; Hawkins F; Liao W; Mora D; Choi S; Wang J; Sun HC; Paschon DE; Guschin DY; Gregory PD; Kotton DN; Holmes MC; Sorscher EJ; Davis BR
    Stem Cell Reports; 2015 Apr; 4(4):569-77. PubMed ID: 25772471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Custom-designed zinc finger nucleases: what is next?
    Wu J; Kandavelou K; Chandrasegaran S
    Cell Mol Life Sci; 2007 Nov; 64(22):2933-44. PubMed ID: 17763826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
    Febbraro F; Chen M; Denham M
    Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.